Transgene signs license agreement with NEC Bio to advance cancer vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. SPY
2. PATH
3. KBH
4. USO
5. AZO
6. QQQ
7. META
8. ORCL
9. RCL
10. ONON

Go back to Transgene signs license agreement with NEC Bio to advance cancer vaccine
NEC Corporation (AMEX: NIPNF) Delayed: 28.40 -2.86 (9.15%)
Previous Close $31.26    52 Week High $3.25 
Open $28.40    52 Week Low $2.10 
Day High $28.40    P/E N/A 
Day Low $28.40    EPS $0.00 
Volume 1,136